Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE)
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
The European journal of cancer
Year: 2016, Jahrgang: 57, Pages: 98-99 |
| ISSN: | 0959-8049 |
| Online-Zugang: |
|
| Verfasserangaben: | S. Paepke, J. Huober [and 16 others] |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 856697281 | ||
| 003 | DE-627 | ||
| 005 | 20220810035358.0 | ||
| 007 | tu | ||
| 008 | 160412s2016 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)856697281 | ||
| 035 | |a (DE-576)985669728X | ||
| 035 | |a (DE-599)GBV856697281 | ||
| 035 | |a (OCoLC)1340145308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Paepke, Stefan |d 1964- |e VerfasserIn |0 (DE-588)17293639X |0 (DE-627)697863484 |0 (DE-576)133790584 |4 aut | |
| 245 | 1 | 0 | |a Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) |c S. Paepke, J. Huober [and 16 others] |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Huober, Jens |e VerfasserIn |0 (DE-588)1059154676 |0 (DE-627)798048239 |0 (DE-576)415183898 |4 aut | |
| 700 | 1 | |a Kümmel, Sherko |d 1971- |e VerfasserIn |0 (DE-588)122704142 |0 (DE-627)082103372 |0 (DE-576)293388016 |4 aut | |
| 700 | 1 | |a Eidtmann, Holger |d 1954- |e VerfasserIn |0 (DE-588)172619130 |0 (DE-627)673654575 |0 (DE-576)133478335 |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |0 (DE-588)134268083 |0 (DE-627)566077914 |0 (DE-576)300413572 |4 aut | |
| 700 | 1 | |a Costa, Serban Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blohmer, Jens-Uwe |d 1962- |e VerfasserIn |0 (DE-588)122376641 |0 (DE-627)081907958 |0 (DE-576)293244227 |4 aut | |
| 700 | 1 | |a Eiermann, Wolfgang |e VerfasserIn |0 (DE-588)1038176131 |0 (DE-627)756738911 |0 (DE-576)175561699 |4 aut | |
| 700 | 1 | |a Gerber, Bernd |d 1957- |e VerfasserIn |0 (DE-588)136713238 |0 (DE-627)585337608 |0 (DE-576)301234620 |4 aut | |
| 700 | 1 | |a Hanusch, Claus Alexander |d 1972- |e VerfasserIn |0 (DE-588)130827525 |0 (DE-627)506018563 |0 (DE-576)298362279 |4 aut | |
| 700 | 1 | |a Hilfrich, Jörn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jackisch, Christian |d 1960- |e VerfasserIn |0 (DE-588)1024193160 |0 (DE-627)71932730X |0 (DE-576)368124908 |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Denkert, Carsten |d 1969- |e VerfasserIn |0 (DE-588)118129929 |0 (DE-627)079261124 |0 (DE-576)291730604 |4 aut | |
| 700 | 1 | |a Engels, Knut |d 1965- |e VerfasserIn |0 (DE-588)143849905 |0 (DE-627)655112243 |0 (DE-576)339348747 |4 aut | |
| 700 | 1 | |a Klare, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fasching, Peter Andreas |d 1975- |e VerfasserIn |0 (DE-588)129068780 |0 (DE-627)388703040 |0 (DE-576)297477099 |4 aut | |
| 700 | 1 | |a Burchardi, Nicole Diana |d 1970- |e VerfasserIn |0 (DE-588)130244295 |0 (DE-627)495827657 |0 (DE-576)298084368 |4 aut | |
| 700 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 700 | 1 | |a Minckwitz, Gunter von |d 1964- |e VerfasserIn |0 (DE-588)172260035 |0 (DE-627)673296962 |0 (DE-576)133128202 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1965 |g Bd. 57.2016, Suppl. 2, Abs. 350, S. S98-S99 |w (DE-627)129271497 |w (DE-600)82061-1 |w (DE-576)014462206 |x 0959-8049 |7 nnas |a Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) |
| 773 | 1 | 8 | |g volume:57 |g year:2016 |g supplement:Suppl. 2 |g pages:98-99 |a Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) |
| 951 | |a AR | ||
| 992 | |a 20200716 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 13 | ||
| 999 | |a KXP-PPN856697281 |e 3725373779 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["856697281"]},"origin":[{"dateIssuedDisp":"2016","dateIssuedKey":"2016"}],"name":{"displayForm":["S. Paepke, J. Huober [and 16 others]"]},"recId":"856697281","relHost":[{"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"type":{"bibl":"periodical"},"language":["eng"],"titleTranslated":[{"translated":"Journal européen de cancérologie"},{"translated":"Europäische Zeitschrift für Cancerologie"}],"title":[{"title_sort":"European journal of cancer","subtitle":"EJC ; the official journal of EORTC, European Organization for Research and Treatment of Cancer, ESO, European School of Oncology, EACR, European Association for Cancer Research, FECS, Federation of European Cancer Societies = Journal européen de cancérologie = Europäische Zeitschrift für Cancerologie","title":"The European journal of cancer"}],"recId":"129271497","disp":"Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE)The European journal of cancer","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Oxford [u.a.] ; Frankfurt, M.","dateIssuedDisp":"1965-","publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1965"}],"id":{"eki":["129271497"],"zdb":["82061-1"],"issn":["0959-8049","0014-2964"]},"note":["Parallelsacht. entfällt ab 7.1971","Repr.: Oxford : Pergamon Press"],"titleAlt":[{"title":"EJC"},{"title":"Europäische Zeitschrift für Cancerologie"},{"title":"Journal européen de cancérolgie"},{"title":"European journal of cancer"}],"pubHistory":["1.1965 - 17.1981,6; 26.1990 - 28.1992,2/3; 33.1997 -"],"part":{"text":"Bd. 57.2016, Suppl. 2, Abs. 350, S. S98-S99","pages":"98-99","volume":"57","year":"2016"}}],"person":[{"display":"Paepke, Stefan","role":"aut","given":"Stefan","family":"Paepke"},{"family":"Huober","role":"aut","given":"Jens","display":"Huober, Jens"},{"display":"Kümmel, Sherko","family":"Kümmel","given":"Sherko","role":"aut"},{"given":"Holger","role":"aut","family":"Eidtmann","display":"Eidtmann, Holger"},{"role":"aut","given":"Michael","family":"Untch","display":"Untch, Michael"},{"display":"Costa, Serban Dan","given":"Serban Dan","role":"aut","family":"Costa"},{"given":"Jens-Uwe","role":"aut","family":"Blohmer","display":"Blohmer, Jens-Uwe"},{"role":"aut","given":"Wolfgang","family":"Eiermann","display":"Eiermann, Wolfgang"},{"display":"Gerber, Bernd","role":"aut","given":"Bernd","family":"Gerber"},{"display":"Hanusch, Claus Alexander","family":"Hanusch","given":"Claus Alexander","role":"aut"},{"display":"Hilfrich, Jörn","given":"Jörn","role":"aut","family":"Hilfrich"},{"family":"Jackisch","role":"aut","given":"Christian","display":"Jackisch, Christian"},{"given":"Andreas","role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas"},{"family":"Denkert","role":"aut","given":"Carsten","display":"Denkert, Carsten"},{"role":"aut","given":"Knut","family":"Engels","display":"Engels, Knut"},{"display":"Klare, Peter","role":"aut","given":"Peter","family":"Klare"},{"role":"aut","given":"Peter Andreas","family":"Fasching","display":"Fasching, Peter Andreas"},{"display":"Burchardi, Nicole Diana","given":"Nicole Diana","role":"aut","family":"Burchardi"},{"display":"Loibl, Sibylle","family":"Loibl","role":"aut","given":"Sibylle"},{"display":"Minckwitz, Gunter von","role":"aut","given":"Gunter von","family":"Minckwitz"}],"title":[{"title":"Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE)","title_sort":"Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE)"}],"type":{"bibl":"article-journal"},"language":["eng"]} | ||
| SRT | |a PAEPKESTEFRANDOMIZED2016 | ||